<DOC>
	<DOCNO>NCT02217878</DOCNO>
	<brief_summary>The purpose IMPRESSION study determine whether intravenous administration morphine prior ticagrelor administration ST-segment elevation myocardial infarction ( STEMI ) patient non-ST-segment elevation myocardial infarction ( NSTEMI ) patient alters plasma concentration ticagrelor active metabolite whether associated negative impact antiplatelet effect ticagrelor .</brief_summary>
	<brief_title>Influence Morphine Pharmacokinetics Pharmacodynamics Ticagrelor Patients With Acute Myocardial Infarction</brief_title>
	<detailed_description>The European Society Cardiology American Heart Association guideline recommend use morphine treatment choice pain relief STEMI patient . However , recommendation , although strong , base expert consensus ( class recommendation I , level evidence C ) . Morphine , apart analgesic effect , also alleviate work breathe reduces anxiety . On hand , despite favorable analgesic sedative action , morphine also exert adverse effect , include hypotension , bradycardia , respiratory depression , vomit reduction gastrointestinal motility . Some previously list morphine 's side effect could affect intestinal absorption thus pharmacokinetics pharmacodynamics orally administer drug concomitantly use morphine . At present , pharmacokinetic pharmacodynamic data regard concurrent use morphine P2Y12 blocker STEMI NSTEMI set available . Therefore , evidence-based verification morphine 's influence pharmacokinetics pharmacodynamics ticagrelor active metabolite ( AR-C124910XX ) could provide valuable insight knowledge regard modern acute myocardial infarction management . Predefined subanalysis : aim investigate one platelet reactivity assessment method utilize study ( VASP assay , MEA , LTA , VerifyNow ) best reflect concentration ticagrelor active metabolite ( AR-C124910XX ) . Since reference study examine pharmacokinetics ticagrelor STEMI NSTEMI patient , decide perform internal pilot study approximately 30 patient ( 15 patient arm ) estimate final sample size .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Morphine</mesh_term>
	<mesh_term>Ticagrelor</mesh_term>
	<criteria>provision inform consent prior study specific procedure diagnosis acute STsegment elevation myocardial infarction acute nonSTsegment elevation myocardial infarction male nonpregnant female , age 1880 year old provision inform consent angiography PCI chest pain describe patient unbearable patient 's request analgesic prior morphine administration current STEMI NSTEMI treatment ticlopidine , clopidogrel , prasugrel ticagrelor within 14 day study enrollment hypersensitivity ticagrelor current treatment oral anticoagulant chronic therapy lowmolecularweight heparin active bleed history intracranial hemorrhage recent gastrointestinal bleeding ( within 30 day ) history coagulation disorder platelet count less &lt; 100 x10^3/mcl hemoglobin concentration le 10.0 g/dl history moderate severe hepatic impairment history major surgery severe trauma ( within 3 month ) patient consider investigator risk bradycardic event second third degree atrioventricular block screen eligibility history asthma severe chronic obstructive pulmonary disease patient require dialysis manifest infection inflammatory state Killip class III IV screen eligibility respiratory failure history severe chronic heart failure ( NYHA class III IV ) concomitant therapy strong CYP3A inhibitor ( ketoconazole , itraconazole , voriconazole , telithromycin , clarithromycin , nefazadone , ritonavir , saquinavir , nelfinavir , indinavir , atazanavir ) strong CYP3A inducer ( rifampicin , phenytoin , carbamazepine , dexamethasone , phenobarbital ) within 14 day study treatment body weight 50 kg</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>ST-segment elevation myocardial infarction</keyword>
	<keyword>non-ST-segment elevation myocardial infarction</keyword>
	<keyword>ticagrelor</keyword>
	<keyword>morphine</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>pharmacodynamics</keyword>
	<keyword>drug interaction</keyword>
	<keyword>VASP assay</keyword>
	<keyword>Multiple Electrode Aggregometry</keyword>
	<keyword>VerifyNow</keyword>
</DOC>